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Abstract
Background: The JNK inhibitor SP600125 strongly inhibits cell proliferation in many human cancer cells by
blocking mitosis progression and inducing cell death. Despite, all this study, the mechanism by which SP600125
inhibits mitosis-related effects in human cervical cells (HeLa cells) remains unclear. In this study, we investigated the
effects of SP600125 on the cell viability, cell cycle, and on the spindle assembly during mitosis in HeLa cells.
Methods: To explore this approach, we used a viability test, an immunofluorescence microscopy to detect Histone
phosphorylation and mitotic spindle aberrations. Apoptosis was characterised using Western Blotting.
Results: Treatment of HeLa cells with varying concentrations of SP600125 induces significant G2/M cell cycle arrest
with elevated phosphorylation of histone H3 within 48 h, and endoreduplication after 48 h. SP600125 also induces
significant abnormal mitotic spindle. High concentrations of SP600125 (20 μM) induce disturbing microtubule
assembly in vitro. Additionally, SP600125- induced delayed apoptosis and cell death was accompanied by
significant poly ADP-ribose polymerase (PARP) cleavage and caspase-3 activation in the late phase (at 72 h).
Conclusion: Our results confirmed that SP600125 induce mitosis arrest in G2/M, endoreduplication, mitotic spindle
aberrations and apoptosis.
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Background
Faithful transmission of genetic information during mi-
tosis is ensured by the spindle assembly checkpoints [1].
Cell cycle progression to the G1, S, and G2/M phases is
controlled by those cell cycle checkpoints that ensure
the correct order and transition timing of the mitotic
spindle [2]. After G2/M arrest, a significant subpopula-
tion of pRb-negative cells demonstrated an excessive
amount of 4 N DNA, known as endoreduplication [3].
Many agents are known for their effect of endoredupli-
cation: agents that interfere with spindle assembly (eg.
Microtubule polylerisation inhibitors eg., colchicines),
the enzyme poisons (eg: amsacrine, and Adriamycin),
catalytic inhibitors (eg: merbarone, aclarubicin) and
physical agents that damage DNA, such as X-rays. Some
of these microtubule-interfering agents, such as
nocodazole and paclitaxel, induce significant endoredu-
plication due to the sister chromatid miss-segregation
[4].
SP600125 is an anthrapyrazolone inhibitor of JNK that
competes with ATP to inhibit the phosphorylation of
c-Jun. Although JNK appears to be involved in cell pro-
liferation, there is no evidence linking JNK activation to
specific phases of the cell cycle. In fact, in Jurkat cells,
JNK activity increased in G2/M checkpoint and was
demonstrated to be responsible for apoptotic Bcl-2
phosphorylation [5]. Recent studies have focused on the
effects of JNK in the promotion of cell death, and it has
been reported that the JNK-antisense oligonucleotide
inhibits tumour growth and induces regression in a high
number of cases [6, 7].
Some research indicates that JNK activity is essential
to maintain proliferation and diploidy in cancer cells.
However, the induction mechanisms of G2/M arrest,* Correspondence: doniamili@gmail.com
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endoreduplication, and apoptosis due to SP600125 still
unclear [8].
In this study, we investigated the relationships between
polyploid giant cells and apoptosis in human cervical
cells treated with SP600125. We tried to explore the
effects of SP600125 in G2/M phase arrest, endoredupli-




The specific JNK inhibitor SP600125 was purchased
from Sigma (S5567). The inhibitor was reconstituted in
DMSO to make a 10 mM stock solution, and DMSO
(0.1%) was used as a control vehicle. MTT, Hoechst
33258. (861405 Sigma Aldrich), were purchased from
Sigma (St. Louis, MO). Triton and FBS were purchased
from GIBCO (Gaithersburg, MD). An enhanced chemi-
luminescence (ECL) kit was purchased from Amersham
(Arlington Heights, IL). Rabbit Anti-Histone H3
(phospho S10) antibody (ab47297). Primary antibodies
were detected using an anti-mouse and anti-rabbit
secondary antibodies conjugated with Alexa Fluorescent.
Cell lines and cell culture
HeLa human carcinoma epithelial cell lines were obtained
from the American type culture collection (ATCC. CCL-
2). Cells were grown in DMEM supplemented with 10%
heat-inactivated FBS and 1% penicillin- streptomycin
(GIBCO) in 5% CO2 at 37 °C. Cells were seeded at 5 × 104
cells/ml and treated with SP600125 at the indicated times.
Cell growth was determined using MTTassays.
Immunofluorescence analysis
For immunofluorescence analysis, Firstly, we brought the
cells, already cultured and transfected on a glass coverslip
in a 24-well plate. The cells were washed three times with
phosphate-buffered saline (PBS) and then fixed with PBS
containing 4% paraformaldehyde at room temperature for
30 min. The fixed cells were washed with PBS containing
0.1% Triton X-100 and then blocked with 1 mg/ml
NaBH4 in PBS. After been blocked, the cells were incu-
bated for 1 h with the primary antibodies, mouse mono-
clonal anti-α-tubulin (F2168 clone DM1A purified
immunoglobulin, monoclonal anti-α-tubulin-FITC
antibody produced in mouse, Sigma Aldrich).
The cells were then washed three times with PBS
containing 0.1% Triton X-100 and incubated with a
secondary antibody, Alexa-fluor 488 anti- Mouse
antibody (62197 Sigma Aldrich) and Alaxa-fluor 568
anti-rabbit Antibody (SAB1102713 Sigma Aldrich) for
20 min, at room temperature and away from light.
For DNA staining, cells were incubated with 5 μg/ml
Hoechst 33342 for 5 min prior to fixation. Glass
coverslip was mounted on a glass slide with the Fluor
save (Calbiochem 34 5789) and examined under a fluor-
escence microscope.
Statistical analysis
All data from cell counts, MTT assays, PARP and
caspase-3 activity experiments were derived from at least
three independent experiments. Images were visualized
with a Zeiss Axiovert 200 M inverted microscope.
Images were captured using CoolSnap HQ (Photomet-
rics) black and white camera driven by the Metamorph
software (Universal Imaging) then downloaded into
Photoshop. Image J (1.49 V) was used to quantify the
Western blots. Statistical analyses were conducted using
Sigma Plot software, and values are presented as mean ±
SD. Significant differences between groups were deter-
mined using an unpaired Student’s t-test. A value of *P
< 0.05 was accepted as an indication of statistical
significance.
Results
SP600125 induces a dose-dependent inhibition in cell via-
bility and expansion of cell size in human HeLa cells
Recent studies have shown that SP600125, a pharmaco-
logical inhibitor of JNK, causes cell viability inhibition in
certain cell types, including breast cancer [8], multiple
myeloma [9], and B-lymphoma [10]. To verify this effect
on cervical cells, HeLa cell line was treated with varying
concentrations of SP600125 for 24 h, 48 h and 72 h. Cell
viability and morphological changes were assessed using
MTT assays and microscopy (Fig. 1).
As shown in Fig. 1(a, a’, a”) significant inhibition of cell
viability in a dose/time-dependent manner was observed
in HeLa cell line. DMSO (0.1%), used as a vehicle
control, did not affect cell viability or morphology.
In other hand, when cells were examined under phase
contrast microscopy, after 48H of incubation cells treated
with 20 μM SP600125 presented with swelling, condensed
nucleus and modest apoptotic shrinkage at 48 h, com-
pared to control cells (Fig. 1b). To confirm that SP600125
inhibited JNK activity, we realised a Western blot analysis
using p-c-Jun antibodies in HeLa cells extract after their
incubation with SP600125 during 48H. As shown in
Fig. 1c, treatment with 20 μM SP600125 almost
completely supressed c-Jun phosphorylation after 48 h.
These results indicate that SP600125 causes anti-
proliferative effects with an apoptotic cell morphology in
cervical cells through inhibition of JNK activity.
SP600125 treatment induces persistence of histone H3
phosphorylation in HeLa cells during mitosis
Some research has shown that Serine 10 (Ser10) phos-
phorylation of histone H3 has emerged as a sensitive
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marker for mitotic cells [11]. In mammalian cells, site-
specific phosphorylation of H3 at Ser10 has been shown
to initiate bulk phosphorylation during prophase,
become maximal during metaphase, diminish during
anaphase and is lost during telophase. Drugs that induce
the phosphorylation of H3 also initiate premature
chromosomal condensation in cell lines. Also, drug-
induced dephosphorylation of H3 were correlated with
chromosome relaxation [12].
In this study, we tried to use this approach by using
antibodies highly selective to the amino-terminus of H3
in a phosphorylated Ser10 form. As shown in Fig. 2a,
Ser10 phosphorylation of histone H3 was retained in
HeLa cells at 48 h. SP600125 time-specifically induced
G2/M phase arrest at 48 h with histone H3 phosphoryl-
ation on Ser10 as a G2/M arrest marker, and then
induced endoreduplication at 48 h (Fig. 2b). Finaly HeLa
cells presented significant signs of apoptosis and
endoreduplication.
SP600125 induces the formation of aberrant mitotic
spindle
Microtubules (MTs) play an important role in cell repli-
cation and division, maintenance of cell shape, and
cellular movement. Microtubules are composed of α-,
β-tubulin, and microtubule-associated proteins (MAPs).
They are in an unstable steady state of a highly dynamic
process of polymerization and depolymerization, and
disrupting the dynamics of microtubules leads to
endoreduplication.
In order to examine the MTs assembly in SP600125-
mediated endoreduplication, we reasoned that the
mitotic spindle itself might be a target of SP600125 ef-
fect. To respond to this question, we examined whether
mitotic cells treated with 20 μM SP600125 displayed
many changes in tubulin polymerization. Treatment with
SP600125 increased the abnormal structure and
promoted an increased intensity of α-tubulin staining,
measured by indirect immunofluorescence (Fig. 3).
Immunofluorescence analysis does not clearly provide a
quantitative measure of tubulin polymerization in the
cell but it shows the formation of aberrant structures:
mini spindle with shifted chromosomes, mini spindle
and spindle with reduced density of microtubules, multi-
polar spindle as shown in Fig. 3 [13].
SP600125 induces apoptosis in HeLa cells after
endoreduplication and aneuploidy
To assess whether delayed apoptosis contributed to the
viability inhibition effects of SP600125, we investigated
the effects of SP600125 on apoptosis.
Apoptosis is controlled by a complex interplay
between many proteins. Bcl-2, a 26-kDa integral mem-
brane oncoprotein, was the first anti-apoptosis gene
product discovered. Several research has demonstrated
that overexpression of Bcl-2 protein protects cells from
apoptosis in some cell lines [12]; although a recent
Fig. 1 a HeLa cells were plated at 5 × 104 cells/ml and incubated for 24 h. Cells were treated with the indicated concentrations of SP600125 and
the cell viability was measured using a metabolic-dye-based MTT assay. Each point represents the mean ± SD of three independent experiments.
Significance was determined using Student’s test (*P < 0.05 vs. vehicle control). a’ HeLa cells were plated at 5 × 104 cells/ml and incubated for
48 h. Cells were treated with the indicated concentrations of SP600125 and the cell viability was measured using a metabolic-dye-based MTT
assay. Each point represents the mean ± SD of three independent experiments. Significance was determined using Student’s test (*P < 0.05 vs.
vehicle control). a”: HeLa cells were plated at 5 × 104 cells/ml and incubated for 72 h. Cells were treated with the indicated concentrations of
SP600125 and the cell viability was measured using a metabolic-dye-based MTT assay. Each point represents the mean ± SD of three independent
experiments. Significance was determined using Student’s test (*P < 0.05 vs. vehicle control). b Cells were incubated with the indicated concentrations
of SP600125. After a 48 h-incubation, cells were sampled and examined under light microscopy. Magnification × 200. c After HeLa cells were treated
with SP600125 for the indicated time, expression of c-Jun and phosphorylated c-Jun was detected using Western blot analysis
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report indicates that the level of this oncoprotein is not
always correlated with an increased ability of the cell to
resist death-promoting stimuli [14]. Recently, some
research, reported that treatment with either okadaic
acid, a potent inhibitor of phosphatase, or the antitubu-
lin agent paclitaxel induced in Bcl-2 protein phosphoryl-
ation and induction of programmed cell death in
lymphoid cells. Suggesting that Bcl-2 phosphorylation
may change its antiapoptotic function. Whereas antican-
cer drugs damaging DNA do not [12].
In this study, in HeLa cells, SP600125 (20 μM)
induced an increase in the multinuclear giant cell popu-
lation (>4 N DNA) (Fig. 4b) and the caspase-3 activation
(Fig. 4a) in a time-dependent manner. Western blot ana-
lysis also demonstrated that SP600125 caused PARP
cleavage and Bcl-2 downregulation (Fig. 4c), suggesting
that the inhibitory effects of SP600125 on cervical cell
viability are dependent on apoptosis.
Discussion
SP600125 has been implicated in G2/M arrest and apop-
tosis, but its precise role remains unknown [15]. The
present study provides the mechanism to explain the in-
duction of G2/M arrest, endoreduplication, and delayed
apoptosis caused by SP600125 in cervical cells.
As shown in Fig. 2a, we have demonstrated that
SP600125 (I- arrests G2/M phases with phosphorylation
of histone H3 at 24 h; (II- suggesting that SP600125
induces endoreduplication; (III- promotes spindle aber-
rations, a critical process in cell division; and (IV-
induces delayed apoptosis in HeLa cells. Therefore,
SP600125 has a strong anticancer effect against cervical
cells in a dose- and time-dependent manner by disturb-
ing tubulin polymerization and disrupting the
organization of the microtubule mitotic cytoskeleton.
The G2/M checkpoint is especially important in pro-
tecting normal cells from tumour formation driven by the
accumulation of mutations [16]. Therefore, elimination of
the checkpoint increases the sensitivity of human tumour
cell lines to anticancer agents. Some studies have reported
that the G2/M arrest induced by SP600125 may be due to
inhibition of cyclin B/Cdk1 kinase activity through an
increase in p21 levels [17, 18]. Increased JNK activity is
important for the dissociation of p21 and JNK, following
which cells enter into the S phases [8].
Using biochemical and immunofluorescence methods,
we have shown that SP60015 significantly increases
tubulin disorders. Microtubules are crucial cellular and
structural components that induce cellular development,
division, and movement [19]. Therefore, microtubule-
Fig. 2 a Histone 3 Phosphorylation was analyzed using immunofluorescent staining in HeLa cells treated with 20 μM SP600125 for the indicated
times. Cells were fixed, permeabilized, and stained. Tubulin tagged with IgG anti-tubulin, H3 phosphorylated was stained with Rabbit Anti-Histone H3
(phospho S10) antibody (ab47297). Primary antibodies was detected using an anti-mouse and anti- rabbit secondary antibodies conjugated with Alexa
Fluorescent (Green for tubulin and Red for H3P). Cells were analyzed using fluorescence microscopy (×400). Hoechst 33258 was used for nuclear staining. b
Endoreduplication detected using Immunofluorescence in HeLa cells treated with 20 μM SP600125 for 48H. Tubulin tagged with IgG anti-tubulin. Primary
antibody was detected using an anti- mouse secondary antibody conjugated with Alexa Fluorescent (Green for tubulin)
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disrupting agents provide a novel approach to cancer
chemoprevention and/or cancer therapy.
Recently, certain cancer chemotherapy agents have
been found to exert their anticancer activities by disrupt-
ing the dynamics of microtubule assembly, thus perturb-
ing the formation and function of the mitotic spindle
apparatus and arresting cells in mitosis [20, 21]. This
action of SP600125 is similar to that of paclitaxel, which
binds to tubulin and increases tubulin polymerization,
causing cells to arrest in the G2/M phase thereby
blocking cell cycle progression [13]. Our results strongly
support the idea that SP600125 inhibits cell proliferation
by inhibiting mitosis through disturbing tubulin
polymerization.
Tumour cells often evade apoptosis by overexpressing
anti-apoptotic proteins, such as Bcl-2, which give them a
survival advantage [22]. Recently, contrasting results
have been reported. In fact, decreased or phosphorylated
Bcl-2 is implicated in the resistance of human ovarian
cancer cells to tubulin polymerizing agents, such as pac-
litaxel [23, 24]. Other reports have shown that Bcl-2
phosphorylation is a common event in mitosis [14].
Our results have shown that the level of endogenous
Bcl-2 expression does not affect SP600125-induced
endoreduplication up to 24 h (Fig. 4c).
Conclusion
In conclusion, our findings indicate a role for both tar-
geting (tubulin polymerization) and signalling (Bcl-2) in
human cervical cells for SP600125. Increased p-histone
H3 protein expressions were found to be responsible for
SP600125-induced G2/M arrest at 48 h and high
Fig. 3 Immunofluorescence analysis shows clearly the formation of aberrant mitotic spindle structure. Spindle perturbation in HeLa cells after
SP600125, Tubulin tagged with IgG anti-tubulin (green fluorescence), and DNA labelled with Hoechst
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SP600125-induced endoreduplication at 48 h. SP600125-
induced delayed apoptosis was related to Bcl-2 expres-
sion, which was closely related to endoreduplication.
Further studies are necessary to clarify the exact mecha-
nisms that are induced by SP600125 involved in specific
stages of cell apoptosis.
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